Sofinnova raises $375M early-stage fund
14th Nov 2006, 19:30 GMT
Sofinnova Ventures, a San Francisco venture firm, closed on its seventh fund after raising $375 million. That surpasses the fund's initial target of $300 million, reflecting institutional investors' robust demand for the high returns expected from firms with a strong track record.
Sofinnova raises $375M early-stage fund related news:
- New test raises hope for early detection of blocked arteries — NewKerala Health News
- Arqule Early Cancer Study Shows Progress — Bio-Technology News from StratCenter.com
- Promising vaccine for early breast cancer — United Press International - Health Business
- Development Finance Institute With a Difference — AllAfrica News: Ghana
- Business and philanthropy in a sometimes rocky union — Europe - International Herald Tribune
- UW crushes Nicholls St. — HeraldNet.com All News
- Venture capital firm raises $260M for investments — bizjournals.com Banking & Financial Services:Venture Capital headlines
- Venture capital firm raises $260 million for investments — Latest news from Baltimore Business Journal
- Zimbabwe Bemoans Latest Rejection By Global Fund On AIDS Funds — VOA News: Health
- World Wildlife Fund (WWF) logo. A hike in temperatures projected ... — World Photos - AFP on Yahoo! News Photos
Latest news from Latest news from San Francisco Business Times:
- San Francisco withdraws Olympic bid
- AT&T picks new western boss
- BOMA chooses Michela Alioto-Pier for award
- Stanford gets $20M gift for cancer stem cell studies
- WorldHeart to cut 50% of employees in shift to new device
- SCM posts $3.9M loss in Q3
- Timbuk2 taps new CEO
- Study: Poor counties get less foundation funding
- BofA awards grants totaling $450,000 to San Francisco
- Corcept Therapeutics to raise $3M in private placement